Pierre Fabre S.a.

P. F. Medicament

Pierre Fabre Cosmetique

Other

Pierre Fabre Medicament

Pierre Fabre Sante

Argentum Holdings S.a.r.l.

Argentum Holding S.a.r.l.

Gilbert Mouzin

Henri Cousse

Antoine Stenger

Jean-Pierre Rieu

Jean-Pierre Tarayre

Andre Delhon

Bernard Bonnaud

Guy Pitet

Marie-Therese Trebosc

M Antoine Stenger

Silvano Casadio

Francois Fauran

Pierre Fabre

Marie Charveron

Pol Vilain

Dennis C Bigg

Jean-Francois Patoiseau

Lucien Dussourd d'Hinterland

Jean-Marie Autin

Michel Morre

Sylvano Casadio

Georges Siegenthaler

Henri Lauressergues

Henry Cousse

Mike Briley

Pitet Guy

Jacques Dubois

Jean-Claude Vezin

Yvon Gall

Stéphanie Thierry

Nicole Monteny

Michel JeanJean

Joy Isaacs

The present invention relates to dermocosmetic compositions containing, as active ingredients, a synergistic combination of colloidal silver and deoxyribonucleic acid, characterized in that the colloidal silver is more particularly an aqueous solution of electro colloidal silver.

Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid

The present invention relates to a dermatological and/or cosmetological composition which is useful in the treatment of pediculosis, characterized in that it contains a synergic combination of a pyrethroid and of crotamiton. The pyrethroids which are the subject of this composition are more particularly permethrin, bioallethrin, resmethrin, tetramethrin and deltamethrin.

Potentialization of pyrethroid by crotamiton which is useful in the

Dermatological and/or cosmetological composition containing retinoids

Liposomes of thermal waters stabilized in a DNA gel

The present invention relates to derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines of the general formula I: ##STR1## and the production thereof. It also concerns pharmaceutical compositions comprising as active principle a compound of general formula I and use thereof for treatment of central nervous system disturbances, especially as an anxiolytic.

Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their

The present invention relates to topical compositions containing caffeine carboxylates with organic bases, which are useful as slenderizing agents and in the treatment of cellulitis, as well as their preparation. The heterogeneous topical compositions of the invention contain, as active principle, a caffeine carboxylic acid which has been salified with a cosmetologically-acceptable organic base, the active principle preferably being present in the form of microparticles or microgranules suspended in a hydroalcoholic gel.

Topical slenderizing formulation containing cafeine carboxylic acid

The present invention relates to a heterogeneous topical composition comprising microgranules or microparticles of a topically-acceptable caffeine metal carboxylate in a hydroalcoholic gel, as well as its preparation and use. The composition, which can be used as slenderizer and/or in the treatment of cellulitis, comprises a long acting topically-acceptable caffeine metal carboxylate as the active principle, which is present in the form of heterogeneously-distributed microgranules or microparticles, having a diameter of about 0.2 to 2 millimeters, suspended in a hydroalcoholic gel in which they are insoluble, advantageously together with Vitamin E or a derivative thereof.

Heterogeneous topical compositions having a base of microgranules of

The invention relates to new derivatives of biphenyl primary alcohols, their preparation and use as medicaments useful in the treatment and prevention of atherosclerotic disorders. The new derivatives have the general formula ##STR1## in which X represents a halogen atom, and more particularly chlorine, bromine or fluorine in ortho or meta position,

Lipid- and cholesterol-reducing derivatives of halo-biphenyl primary

2-Alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-Triazines of the formula I ##STR1## wherein R and R.sub.1, which may be identical or different, represent hydrogen, alkyl, alkoxy, hydroxy, dialkylamino, or halogen,

2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as

The present invention relates to new 2-(arylalkyloxymethyl)morpholine derivatives, the preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system. The 2-(arylalkyloxymethyl)morpholine derivatives according to the invention correspond to the general formula (I): ##STR1## in which: Ar denotes an aromatic group and more especially the following radicals: ##STR2## in the case where Ar denotes a phenyl radical and R denotes a hydrogen atom, an alkyl, alkoxy or halogen group, a trifluoromethyl radical, a nitro or amino group, a hydroxy group or an arylalkyloxy group.

2-(arylalkyloxymethyl)morpholines and the central nervous system

The present invention concerns new derivatives of 1-aryl 2-aminomethyl cyclopropane carboxylates (Z), their preparation and their use as useful drugs for the treatment of various pains. The new derivatives of the present invention have the general formula I ##STR1## in which: R represents a hydrogen or halogen atom, a C.sub.1 to C.sub.4 lower alkyl group, a C.sub.1 to C.sub.4 lower alkoxy group, or a nitro, amino, sulfamoyl or hydroxy group;

1-Aryl 2-aminomethyl cyclopropane carboxylates (Z)

The present invention concerns a novel process for the production of new chemical compounds of the general formula: ##STR1## in which: R.sub.1 and R.sub.2 may be identical or different and represent a hydrogen or halogen atom or else a lower alkyl, lower alkoxy, nitro or acetyl group and

Preparation of 3-amino-1-[(1,4-benzodioxan)-2-yl-methoxy]-2-propanols

The present invention concerns new 2-N-cycloalkylmethyl 3-oxo 5,6-diaryl as-triazines, their method of production, pharmaceutical compositions thereof, and their use as medicaments, for treating pain. The derivatives of 2-N-cycloalkylmethyl 3-oxo 5,6-diaryl as-triazine according to the invention have the general formula I ##STR1## in which Ar represents a phenyl, furyl, thienyl, or pyridyl group, which group may possibly be substituted by a lower C.sub.1 to C.sub.4 alkoxy radical, in particular by the methoxy radical, and

2-N-Cycloalkylmethyl 3-oxo 5,6-diaryl-as-triazines

This invention relates to new derivatives of biphenyl alkyl carboxylates, to a process for the preparation thereof and the use thereof as medicaments. The new derivatives according to the present invention correspond to general formula (I): ##STR1## wherein X represents a hydrogen atom or a halogen atom,

Derivatives of biphenyl alkyl carboxylates and their use as medicaments

1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) as drugs in the

Growing community of inventors

Castres, France

Gilbert Mouzin